| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-03-26 | 2025-03-26 | 2024-03-11 | 2023-03-08 | 2022-03-23 | 2020-12-31 | 2019-12-31 |
| Revenue | 31.7 | 31.7 | 43.87 | 41.66 | 33.2 | 23.35 | 34.73 |
| Cost of Revenue | 19.86 | 19.86 | 33.14 | 31.18 | 24.86 | 19.47 | 25.66 |
| Gross Profit | 11.84 | 11.84 | 10.72 | 10.48 | 8.34 | 3.88 | 9.07 |
| Operating Expenses | 41.19 | 41.21 | 68.47 | 68.68 | 52.48 | 47.16 | 54.53 |
| Research & Development | 6.76 | 6.76 | 10.24 | 16.78 | 18.57 | 20.46 | 18.97 |
| Selling, General and Administrative | 34.45 | 34.45 | 52.11 | 51.91 | 33.91 | 26.7 | 35.56 |
| Other Operating Expenses | -0.015 | 0 | 6.12 | 0 | 0 | 0 | 0 |
| Operating Income | -29.35 | -29.37 | -57.74 | -58.2 | -44.15 | -43.27 | -45.46 |
| Net Non-Operating Interest | -4.57 | -5.47 | -3.17 | -3.23 | -4.21 | -3.96 | -2.84 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.57 | 5.47 | 3.17 | 3.23 | 4.21 | 3.96 | 2.84 |
| Equity & Other Income/(Expense) | 0.383 | 1.3 | -1.54 | 4.38 | -0.138 | 0.569 | -0.995 |
| Income Before Tax | -33.54 | -33.54 | -62.46 | -57.05 | -48.5 | -46.66 | -49.3 |
| Income Tax Expense | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
| Income Attributable to Non-Controlling Interest | -5.51 | -5.51 | -1.54 | 0 | 0 | 0 | 0 |
| Net Income | -28.03 | -28.03 | -60.92 | -57.05 | -48.5 | -46.66 | -49.3 |
| Depreciation and Amortization | 1.46 | 1.46 | 2.98 | 2.82 | 3 | 3.57 | 2.99 |
| EBITDA | -27.89 | -27.91 | -54.77 | -55.39 | -41.15 | -39.7 | -42.47 |
| Earnings Per Share (EPS) | -0.358 | -0.59 | -0.65 | -1.27 | -2.14 | -2.53 | -41.33 |
| Diluted Earnings Per Share | -0.358 | -0.59 | -0.65 | -1.27 | -2.14 | -2.53 | -41.33 |
| Weighted Average Shares Outstanding | 47.71 | 47.49 | 93.99 | 44.93 | 22.63 | 18.47 | 1.19 |
| Diluted Weighted Average Shares Outstanding | 47.71 | 47.49 | 93.99 | 44.93 | 22.63 | 18.47 | 1.19 |
